Literature DB >> 9420320

Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program.

D Vlahov1, B Junge, R Brookmeyer, S Cohn, E Riley, H Armenian, P Beilenson.   

Abstract

OBJECTIVE: To determine whether enrollment in the Baltimore Needle Exchange Program (NEP) was associated with short-term reduction in risky injection practices.
METHODS: Demographic information was collected on NEP participants upon enrollment. A systematic sample of enrollees was interviewed at program entry, 2 weeks, and 6 months later on recent drug-related behaviors. Comparisons were performed using paired t-tests.
RESULTS: Among 221 NEP participants who completed baseline, 2-week and 6-month follow-up visits, significant reductions (p < .01) were reported in using a previously used syringe (21.6%, 11.0%, 7.8%, respectively), lending one's used syringe to a friend (26.7%, 18.4%, 12%, respectively), and several indirect sharing activities. Reductions were reported in the mean number of injections per syringe and the mean number of injections per day (p < .001).
CONCLUSIONS: These results show rapid and mostly large reductions in a variety of risky injection drug use behaviors. Study findings are consistent with earlier reports showing an association between behavioral risk reduction and participation in a needle exchange program.

Entities:  

Mesh:

Year:  1997        PMID: 9420320     DOI: 10.1097/00042560-199712150-00014

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  43 in total

1.  Volunteer bias in nonrandomized evaluations of the efficacy of needle-exchange programs.

Authors:  H Hagan; J P McGough; H Thiede; S G Hopkins; N S Weiss; E R Alexander
Journal:  J Urban Health       Date:  2000-03       Impact factor: 3.671

2.  Selective risk taking among needle exchange participants: implications for supplemental interventions.

Authors:  T W Valente; D Vlahov
Journal:  Am J Public Health       Date:  2001-03       Impact factor: 9.308

3.  Trends in crime and the introduction of a needle exchange program.

Authors:  M A Marx; B Crape; R S Brookmeyer; B Junge; C Latkin; D Vlahov; S A Strathdee
Journal:  Am J Public Health       Date:  2000-12       Impact factor: 9.308

4.  Giving means receiving: the protective effect of social capital on binge drinking on college campuses.

Authors:  E R Weitzman; I Kawachi
Journal:  Am J Public Health       Date:  2000-12       Impact factor: 9.308

5.  Characteristics and utilization patterns of needle-exchange attendees in Chicago: 1994-1998.

Authors:  H Brahmbhatt; D Bigg; S A Strathdee
Journal:  J Urban Health       Date:  2000-09       Impact factor: 3.671

6.  Prevalence and predictors of transitions to and away from syringe exchange use over time in 3 US cities with varied syringe dispensing policies.

Authors:  Traci C Green; Ricky N Bluthenthal; Merrill Singer; Leo Beletsky; Lauretta E Grau; Patricia Marshall; Robert Heimer
Journal:  Drug Alcohol Depend       Date:  2010-05-26       Impact factor: 4.492

Review 7.  The provision of non-needle/syringe drug injecting paraphernalia in the primary prevention of HCV among IDU: a systematic review.

Authors:  Michelle Gillies; Norah Palmateer; Sharon Hutchinson; Syed Ahmed; Avril Taylor; David Goldberg
Journal:  BMC Public Health       Date:  2010-11-23       Impact factor: 3.295

Review 8.  The role of needle exchange programs in HIV prevention.

Authors:  D Vlahov; B Junge
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

9.  Consequences of a restrictive syringe exchange policy on utilisation patterns of a syringe exchange program in Baltimore, Maryland: Implications for HIV risk.

Authors:  Susan G Sherman; Shivani A Patel; Daesha V Ramachandran; Noya Galai; Patrick Chaulk; Chris Serio-Chapman; Renee M Gindi
Journal:  Drug Alcohol Rev       Date:  2015-04-28

10.  Marginalized and socially integrated groups of IDUs in Hungary: potential bridges of HIV infection.

Authors:  V Anna Gyarmathy; Alan Neaigus
Journal:  J Urban Health       Date:  2005-09       Impact factor: 3.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.